Patients with diabetes and a history of atrial fibrillation (AF) have fewer diabetic complications and lower mortality rates when prescribed non-vitamin K antagonist oral anticoagulants (NOACs) rather ...
Thromboembol in blood vessel. Clot formation, 3D illustration Experts review the current indications for NOACs as well as research on use as venous thromboembolism (VTE) prophylaxis in patients with ...
A retrospective cohort study of patients with atrial fibrillation and diabetes found that the use of non–vitamin K antagonist oral anticoagulants (NOAC) was associated with a lower risk of diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results